These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19874086)

  • 1. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
    Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
    J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
    Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1.
    Kamiya N; Kaartinen VM; Mishina Y
    Biochem Biophys Res Commun; 2011 Oct; 414(2):326-30. PubMed ID: 21945937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
    Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
    Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of BMPs in bone anabolism and their potential targets SOST and DKK1.
    Kamiya N
    Curr Mol Pharmacol; 2012 Jun; 5(2):153-63. PubMed ID: 21787290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins.
    Winkler DG; Sutherland MS; Ojala E; Turcott E; Geoghegan JC; Shpektor D; Skonier JE; Yu C; Latham JA
    J Biol Chem; 2005 Jan; 280(4):2498-502. PubMed ID: 15545262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
    Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
    Choi HY; Dieckmann M; Herz J; Niemeier A
    PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
    Hie M; Iitsuka N; Otsuka T; Tsukamoto I
    Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
    Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
    J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
    Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
    J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOST Inhibits Prostate Cancer Invasion.
    Hudson BD; Hum NR; Thomas CB; Kohlgruber A; Sebastian A; Collette NM; Coleman MA; Christiansen BA; Loots GG
    PLoS One; 2015; 10(11):e0142058. PubMed ID: 26545120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
    Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
    Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
    Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
    Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF.
    Fujita K; Janz S
    Mol Cancer; 2007 Oct; 6():71. PubMed ID: 17971207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.
    Zhang R; Oyajobi BO; Harris SE; Chen D; Tsao C; Deng HW; Zhao M
    Bone; 2013 Jan; 52(1):145-56. PubMed ID: 23032104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.